Skip to main content
. 2010 Mar 2;4(3):e614. doi: 10.1371/journal.pntd.0000614

Table 2. Worm burdens in Cry5B treatment experiments.

Group (no. of mice) Intestinal worm burden (mean ± sem) % Reduction relative to placebo
HD1 placebo (10) 59.1±11.1 NA
Cry5B (10) 19.4±3.6 67.2
4Q7 placebo (7) 169.1±14.0 NA
Cry5B (7) 48.1±15.3 71.5

placebo: crystal-deficient HD1 or 4Q7 strain; Cry5B: the corresponding strain transformed with a Cry5B-expressing plasmid. Cry5B dosage: 715 nm/kg (HD1) or 644 nm/kg (4Q7).

sem  =  standard error of the mean.

NA  =  not applicable.